Carbabac IV Injection or Infusion
IV Injection or Infusion
Pharmasia LimitedGeneric:
Meropenem TrihydrateWeight:
1 gm/vialbest Price:
৳ 1,200.00Generic
Meropenem Trihydrate
Contraindications
Meropenem should be administered by intravenous Infusion over approximately 15-30 minutes or as intravenous bolus (5 to 20 ml) over approximately 3-5 minutes
Pregnancy And Lactation
Probenecid competes with Meropenem for active tubular secretion and thus inhibits the renal excretion, with the effect of increasing the elimination half-life and plasma concentration of meropenem. Meropenem may reduce serum valproic acid levels. Sub therapeutic levels may be reached in some patients.
Therapeutic
Meropenem is generally well tolerated. Side effects like inflammation, thrombophlebitis, pain at the site of injection, skin reactions like rash, pruritus, urticaria, abdominal pain, nausea, vomiting, diarrhea, headache may occur.
Storage Conditions
Renal impairment: Dosage should be reduced in patients with creatinine clearance less than 51 ml/min. Hepatic impairment: No dosage adjustments are necessary with impairment of liver function. Hemodialysis patients should receive Meropenem after dialysis has been completed. Elderly: No dosage adjustments are necessary in elderly patients unless creatinine clearance is <51 ml/min. Use in Children: Efficacy and tolerability in infants under 3 months have not been established.